How does a physician decide which pharmacotherapeutic option to select for acute migraine attacks?

Expert Opin Pharmacother. 2022 Jul;23(10):1129-1133. doi: 10.1080/14656566.2022.2060740. Epub 2022 Apr 5.

Authors

Elena P Calandre¹, Mahmoud Slim¹, Fernando Rico-Villademoros¹

Affiliation

¹ Instituto de Neurociencias, Universidad de Granada, Armilla, Spain.

PMID: 35382662
DOI: 10.1080/14656566.2022.2060740

No abstract available

Keywords: drug classes; migraine; patient-specific factors; symptomatic treatment.

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Humans
Migraine Disorders* / drug therapy
Physicians*

Substances

Anti-Inflammatory Agents, Non-Steroidal